Antares Pharma Inc (NASDAQ:ATRS)

2.20
Delayed Data
As of 4:00pm ET
 -0.03 / -1.35%
Today’s Change
1.58
Today|||52-Week Range
4.09
+10.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-20.5M-35.2M-20.7M-24.3M
 
 
 
 
 
Depreciation493.3K1.2M1.6M1.9M
 
 
 
 
 
Total Other Cash Flow5.1M6.2M4.5M3.5M
 
 
 
 
 
Funds From Operations-14.9M-27.7M-14.6M-18.9M
 
 
 
 
 
Funds From/For Other Operating Expenses39.9K-1.4M13.7M-3.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-15.0M-26.3M-28.3M-15.2M
 
 
 
 
 
 
InvestingIncrease In Investments-21.1M0.00-15.0M0.00
 
 
 
Decrease In Investments24.0M24.0M6.0M15.0M
 
 
 
 
 
Capital Expenditures-2.7M-4.7M-5.6M-4.9M
 
 
 
 
 
Net Cash Flow Investing-293.1K18.3M-15.7M10.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale2.3M3.1M42.9M101.1K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing----0.00----
Other Uses - Financing104.3K154.4K0.0083.6K
 
 
 
 
Net Cash Flow - Financing2.2M3.0M42.9M17.5K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash8.9K-2.6K-733.0058.00
 
 
 
 
 
 
Net Change In Cash-13.0M-5.0M-1.1M-5.2M